During the past decade, Clinique Saint-Joseph conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 27 clinical trials were completed, i.e. on average, 79.4% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 18 clinical trials were completed. i.e. 1800% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique Saint-Joseph" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Celgene" with 5 trials sponsored, "Galapagos NV" with 5 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 4 trials sponsored and "Boehringer Ingelheim" with 4 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Saint-Joseph" #1 collaborator was "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator, "Takeda" with 3 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator and "Bristol-Myers Squibb" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Saint-Joseph" are "Breast Cancer" (8 trials), "Ulcerative Colitis" (5 trials), "Colorectal Cancer" (4 trials), "Crohn's Disease" (3 trials) and "Breast Neoplasms" (2 trials). Many other conditions were trialed in "Clinique Saint-Joseph" in a lesser frequency.

Most popular intervention types in "Clinique Saint-Joseph" are "Drug" (58 trials), "Device" (4 trials), "Radiation" (3 trials), "Biological" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Trastuzumab" (5 trials), "Filgotinib" (4 trials), "fluorouracil" (4 trials) and "Capecitabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Saint-Joseph" are 55 trials for "All" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "Clinique Saint-Joseph". undefined are not yet recruiting, 2 are recruiting, 10 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 42 completed trials in Clinique Saint-Joseph, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Saint-Joseph, 1 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 2 trials that are defined as “Not Applicable".